Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASCO Conference
Trial Participation Hampered by Costs
ASCO Conference
September 2010, Vol 1, No 4
Cost-related factors are a chief reason for patients declining to participate in a clinical trial, a survey of 4 community oncology practices showed.
Read Article
ASCO Weighs in on CER
ASCO Conference
September 2010, Vol 1, No 4
The American Society of Clinical Oncology (ASCO) stated that comparative effectiveness research (CER) should draw on approaches currently used for clinical trials, highlighting its stake in the matter by pointing out that CER is integral to oncology research.
Read Article
Greater Role for Pharmacogenomics Ahead
ASCO Conference
September 2010, Vol 1, No 4
Chicago, IL—Using genetic and pharmacogenomic information to treat patients with cancer in optimal fashion has advanced in the past several years, and the clinical utility of this approach should continue to improve as genetic research continues, said several panelists at a 2010 ASCO session on evaluating the evidence and marketing of genomic tests.
Read Article
Bevacizumab Cost-Effectiveness “in Line” with Other Therapies
ASCO Conference
September 2010, Vol 1, No 4
Chicago, IL—The cost-effectiveness of adding bevacizumab (Avastin) to first-line chemotherapy for the treatment of metastatic colorectal cancer is comparable to that of many other therapies for metastatic cancer.
Read Article
Active Surveillance Cost-Effective for Low-Risk Prostate Cancer
ASCO Conference
September 2010, Vol 1, No 4
Chicago, IL—Active surveillance is a cost-effective option for low-risk clinically localized prostate cancer.
Read Article
Fostering Clinical Research in the Community Setting
ASCO Conference
September 2010, Vol 1, No 4
Chicago, IL—Taking part in clinical research poses administrative, logistic, and financial challenges to community oncology practices, but also presents these organizations with opportunities for a more active role in shaping patient care.
Read Article
Comparative Effectiveness Research in Oncology Is High Priority
ASCO Conference
September 2010, Vol 1, No 4
Read Article
Cost-Effectiveness in the New Comparative Effectiveness Landscape
ASCO Conference
September 2010, Vol 1, No 4
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma